Insulin glargine (HOE901): first responsibilities: understanding the data and ensuring safety
- PMID: 10834411
- DOI: 10.2337/diacare.23.5.576
Insulin glargine (HOE901): first responsibilities: understanding the data and ensuring safety
Comment on
-
Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.Diabetes Care. 2000 May;23(5):639-43. doi: 10.2337/diacare.23.5.639. Diabetes Care. 2000. PMID: 10834423 Clinical Trial.
-
Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo.Diabetes Care. 2000 May;23(5):644-9. doi: 10.2337/diacare.23.5.644. Diabetes Care. 2000. PMID: 10834424 Clinical Trial.
Similar articles
-
Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes.Diabetes Care. 2001 Feb;24(2):411-2. doi: 10.2337/diacare.24.2.411. Diabetes Care. 2001. PMID: 11213905 No abstract available.
-
Insulin glargine.Am J Health Syst Pharm. 2000 Nov 1;57(21):1960-1. doi: 10.1093/ajhp/57.21.1960. Am J Health Syst Pharm. 2000. PMID: 11094649 No abstract available.
-
Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes.Diabetes Care. 2001 Nov;24(11):2005-6. doi: 10.2337/diacare.24.11.2005. Diabetes Care. 2001. PMID: 11679478 Clinical Trial. No abstract available.
-
Insulin glargine: a new basal insulin analogue.QJM. 2002 Nov;95(11):757-61. doi: 10.1093/qjmed/95.11.757. QJM. 2002. PMID: 12391389 Review. No abstract available.
-
Insulin glargine: a new long-acting insulin product.Am J Health Syst Pharm. 2002 Apr 1;59(7):643-9. doi: 10.1093/ajhp/59.7.643. Am J Health Syst Pharm. 2002. PMID: 11944604 Review.
Cited by
-
Insulins for the long term management of diabetes mellitus in dogs: a review.Canine Med Genet. 2022 Feb 14;9(1):1. doi: 10.1186/s40575-022-00114-9. Canine Med Genet. 2022. PMID: 35152907 Free PMC article. Review.
-
The Comparative Dosing and Glycemic Control of Intermediate and Long-Acting Insulins in Adult Patients With Type 1 and 2 Diabetes Mellitus.J Pharm Technol. 2022 Feb;38(1):46-53. doi: 10.1177/87551225211055700. Epub 2021 Nov 10. J Pharm Technol. 2022. PMID: 35141727 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical